American Fusion Inc. (OTCQB: AMFN) Reports Pulsed-Power Equipment Upgrades, Four Commercial Proposals Under Negotiation and Scientific Review of Texatron™ Technical Report

American Fusion advances fusion tech discussions but remains pre-revenue with no signed deals.

What the company is saying

American Fusion Inc. is highlighting progress on three fronts: commercial engagement, technical development, and capital markets planning. The company reports having delivered four commercial proposals for potential Texatron™ Fusion Engine™ deployments, with one proposal revised four times, and all proposals still under discussion. It has sent one letter of intent but does not clarify if this overlaps with the proposals, and counterparties remain unnamed. The company is also in talks with four out of five additional data center developers as prospects, with outreach ongoing to the fifth. The technical narrative centers on Dr. John E. Brandenburg, Chief Technology Officer, whose manuscript on the Texatron™ platform is now under scientific review, with plans for public release after publication. Executive Chairman Brent Nelson emphasizes that commercial interest is developing in parallel with technical progress, but stresses that meaningful milestones will require validated testing and executed agreements. The company is also evaluating multiple financing proposals and potential uplisting to national exchanges, but no exchange has been selected and no investment banking engagement has been finalized.

What the data suggests

The company has delivered four commercial proposals, all still in negotiation, and one letter of intent, with no indication of executed agreements or revenue. One proposal has undergone four revisions, suggesting active but unresolved negotiations. Discussions are ongoing with four of five identified data center developers, but no contracts or partnerships have been secured. Technical progress includes upgrades to electrical switching and capacitor banks, and the setup for further pulsed-power experiments. The technical manuscript by Dr. Brandenburg is still under review, and no peer-reviewed validation or experimental results have been disclosed. The company is evaluating additional Texas testing locations and considering neutron-detection instrumentation, but no site has been committed to. Financing discussions and uplisting ambitions are described as ongoing, with no disclosed commitments or selected exchange. All disclosed facts point to a company still in the pre-revenue, pre-validation stage, with operational and commercial milestones yet to be achieved.

Analysis

The announcement is upbeat and details multiple operational steps—such as commercial proposals delivered, technical manuscript preparation, and equipment upgrades—but all commercial activity remains at the proposal or discussion stage, with no executed agreements, revenue, or deployments. The majority of key claims are forward-looking, including the commercial model, exchange uplisting, and financing, all of which are contingent on future validation, regulatory approvals, and successful fundraising. The company discloses ongoing capital requirements and is evaluating financing structures, but there is no evidence of committed funding or near-term earnings impact. The technical progress described (equipment upgrades, manuscript under review) is incremental and does not yet translate into commercial or financial milestones. The tone is optimistic, but the gap between narrative and realised progress is significant, as all major benefits are long-dated and uncertain. The absence of financial or profitability metrics further limits the strength of the signal.

Risk flags

• ●Execution risk is high, as all commercial proposals and letters of intent remain under discussion with no signed agreements, and the company has not disclosed counterparties or terms. This leaves the path to revenue and commercial deployment uncertain.
• ●Technical risk is significant, as the Texatron™ Fusion Engine™ has not demonstrated fusion ignition, net energy gain, or commercial electrical generation. The key technical manuscript is still under review, and no experimental validation or peer-reviewed results have been released.
• ●Financing and capital markets risk is present, as the company is evaluating multiple financing proposals and uplisting opportunities but has not secured committed funding or selected an exchange. Commercialization and continued operations depend on future successful fundraising.
• ●Disclosure risk exists, as the company provides operational detail but omits all financial metrics, including cash position, revenue, or contract values. This lack of financial transparency limits investor ability to assess financial health or runway.

Bottom line

American Fusion Inc. remains in the early stages of commercial and technical development, with all commercial proposals, letters of intent, and financing discussions still in progress and no executed agreements or revenue. Technical upgrades and manuscript review indicate ongoing R&D, but there is no disclosed experimental validation or independent scientific endorsement. The company’s narrative is forward-looking, with major milestones such as peer-reviewed publication, measurable experimental data, signed customer agreements, and exchange uplisting all contingent on future success. Investors should recognize that all value drivers are long-dated and subject to high execution and technical risk. The most important takeaway is that American Fusion is pre-revenue, pre-validation, and has yet to convert discussions into tangible commercial or financial outcomes.

Announcement summary

(OTCQB:AMFN) American Fusion Inc. provided an update on its Texatron™ Fusion Engine™ testing program, commercial development discussions, and a technical manuscript prepared by Chief Technology Officer Dr. John E. Brandenburg. The company has delivered four commercial proposals for potential Texatron™ deployments, with one proposal having undergone four revisions, and all proposals remain in active discussions. American Fusion has also sent one letter of intent, but has not disclosed whether it relates to one of the four proposals, and has not identified the counterparties. The company is in discussions with four of five additional data center developers it has identified as potential prospects and is seeking contact with the fifth. Its commercial model contemplates retaining ownership and operation of Texatron™ systems and supplying electricity through negotiated long-term arrangements, subject to successful technology validation, financing, regulatory requirements, and definitive agreements. The Texatron™ platform uses a proprietary Rifled Toroidal Pinch (RTP) architecture, combining pulsed-power plasma compression with toroidal magnetic confinement, and features a precision-machined chamber with helical grooves to influence magnetic-field structure during plasma formation. Dr. Brandenburg’s technical manuscript, which analyzes magnetic-flux properties such as helicity and baricity and introduces the Double Invariant framework and Energy Scale Invariance principle, is currently undergoing scientific review. The company intends to provide additional information as the review process progresses and to make the report publicly available following formal publication. American Fusion has upgraded its electrical switching capabilities and set up higher-capacity capacitor banks for the next phase of pulsed-power experiments, aiming to improve the delivery and control of electrical pulses for plasma formation and magnetic compression. The company is discussing neutron-detection instrumentation to obtain measurable experimental data and is evaluating additional potential Texas testing locations for greater flexibility in its experimental program. Before committing to a site, the company will assess facility suitability, equipment, safety requirements, and available diagnostic capabilities. American Fusion is also engaged in discussions with investment banking and capital markets firms regarding potential financing and advisory relationships in connection with its longer-term national exchange uplisting strategy. The company has evaluated multiple financing proposals and continues to assess potential relationships and structures to support its capital requirements and commercialization objectives. American Fusion is evaluating potential future national securities exchange uplisting opportunities, including the Texas Stock Exchange, Nasdaq, and the New York Stock Exchange, but has not selected an exchange or entered into a definitive investment banking engagement. Any potential listing would depend on eligibility requirements, approvals, financing, and market conditions. The company emphasizes that meaningful progress must be demonstrated through testing results and executed agreements.

Disagree with this article?